About Contact Us Careers

Critical Care Diagnostics Market Size and Forecast, by Type (Routine & Special Chemistry, Flow Cytometry, Hematology, Immunoproteins, Microbial & Infectious Disease, Coagulation Testing); Product (Glucose Monitoring, Cardiometabolic Monitoring, Infectious Disease, Coagulation Monitoring, Cancer Markers, Hematology, Pregnancy and Fertility, Cholesterol, Drugs-Of-Abuse & Fecal Occult Testing Kits) - Growth Trends, Key Players, Regional Analysis 2026-2035

  • Report ID: 5813
  • Published Date: Sep 16, 2025
  • Report Format: PDF, PPT

Critical Care Diagnostics Market Outlook:

Critical Care Diagnostics Market size was over USD 1.46 billion in 2025 and is projected to reach USD 2.54 billion by 2035, growing at around 5.7% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of critical care diagnostics is evaluated at USD 1.53 billion.

Critical Care Diagnostics Market
Discover Market Trends & Growth Opportunities: Request Free Sample PDF

The reason behind the growth is due to the growing burden of cancer across the globe. For instance, there are an estimated 0.7 million new instances of cancer annually, indicating a constant increase in poor diet, alcohol use, smoking, physical inactivity, air pollution, and other noncommunicable illnesses, which are exacerbated by aging and population expansion.

According to the World Health Organization (WHO), it is anticipated that there will be over 35 million new cases of cancer in 2050, a 77% increase over the projected 20 million cases in 2022.

The growing development of quick diagnostic tools is believed to fuel the critical care diagnostics market growth. Without the need for complex equipment, the latest generation of miniaturized biosensor technologies for point-of-care testing has produced a more sensitive, dependable, quick, and economical detection procedure, which has benefited the clinical management of numerous applications, including pathology, drug discovery, and food safety.

Key Critical Care Diagnostics Market Insights Summary:

  • Regional Highlights:

    • North America critical care diagnostics market will dominate around 45% share, driven by increased spending on healthcare and investment in advanced diagnostic technologies, forecast period 2026–2035.
    • Asia Pacific market will hold the second largest share, fueled by rising medical tourism and affordable, high-quality treatments in India, forecast period 2026–2035.

  • Segment Insights:

    • The immunoproteins segment in the critical care diagnostics market is projected to capture a 37% share by 2035, driven by the role of immunoproteins in diagnosing cancer, autoimmune, and infectious diseases.
    • The emergency rooms segment in the critical care diagnostics market is anticipated to gain notable revenue share by 2035, driven by the need for rapid and life-saving diagnostics in emergency care situations.

  • Key Growth Trends:

    • Rising Geriatric Population
    • Growing Prevalence of Cardiovascular Disorders

  • Major Challenges:

    • Exorbitant Cost of Critical Care Diagnostics

  • Key Players: F. Hoffmann-La Roche Ltd, Danaher, BD, EKF Diagnostics, bioMérieux, Inc., Siemens Healthcare Private Limited, Chembio Diagnostics, Inc., Bayer AG.

Global Critical Care Diagnostics Market Forecast and Regional Outlook:

  • Market Size & Growth Projections:

    • 2025 Market Size: USD 1.46 billion
    • 2026 Market Size: USD 1.53 billion
    • Projected Market Size: USD 2.54 billion by 2035
    • Growth Forecasts: 5.7% CAGR (2026-2035)

  • Key Regional Dynamics:

    • Largest Region: North America (45% Share by 2035)
    • Fastest Growing Region: Asia Pacific
    • Dominating Countries: United States, Germany, China, Japan, United Kingdom
    • Emerging Countries: China, India, Japan, South Korea, Brazil

    • Last updated on : 16 September, 2025

Growth Drivers

  • Rising Geriatric Population – A rising percentage of severely ill patients admitted to intensive care units are adult individuals who have complex medical and social needs, and who survive serious illnesses such as sepsis or respiratory failure. For instance, just between 2000 and 2050, the percentage of adults 80 and older worldwide will rise to over 4%.
  • Growing Prevalence of Cardiovascular Disorders- The level of risk can be ascertained by undergoing a cardiovascular risk assessment which usually takes a combination of imaging, cardiac monitoring, and blood testing to diagnose a heart condition. As per the World Health Organization (WHO), globally, cardiovascular diseases (CVDs) account for 17.9 million deaths annually, making them the leading cause of death.
  • Surging Incidence of Lifestyle-related Disorders- Type 2 diabetes and high blood pressure are a few lifestyle diseases that share risk factors with extended exposure to three modifiable lifestyle factors and involve enhanced diagnostics and medication, as well as intense disability management and extended care.

Challenges

  • Exorbitant Cost of Critical Care Diagnostics- Intensive care units, or ICUs, are expensive facilities owing to the admission of patients with complex and life-threatening illnesses, the utilization of costly instruments and equipment, and the increased staffing ratio per patient.
  • It's common to characterize critical care as costly treatment since these treatments are labor-intensive, and they have an overabundance of patients, owing to their extended hospital stays, survivors of critical care may incur higher hospital costs. As ICU survivors depart the hospital, their experience in intensive care may leave them with ongoing, long-term health issues, and in lower-income nations, patients typically pay out-of-pocket for their visits since critical care costs are also frequently not fully covered by health insurance systems.
  • Resource Constraints in many low-income regions such as a lack of skilled professionals
  • Inadequate infrastructure in remote areas can impact the delivery of critical care diagnostics

Critical Care Diagnostics Market Size and Forecast:

Report Attribute Details

Base Year

2025

Forecast Period

2026-2035

CAGR

5.7%

Base Year Market Size (2025)

USD 1.46 billion

Forecast Year Market Size (2035)

USD 2.54 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Access Detailed Forecasts & Data-Driven Insights: Request Free Sample PDF

Critical Care Diagnostics Market Segmentation:

Type Segment Analysis

The immunoproteins segment in the critical care diagnostics market is estimated to gain a robust revenue share of 37% in the coming years. Immunoprotein diagnostic testing is defined as the process of examining particular proteins produced by the immune system such as cytokines, antigens, or antibodies in the body to examine illnesses associated with particular proteins, including immunoglobulin, pre-albumin, and others. Immunoproteins are blood proteins that are essential to the immune system's operation and perform a crucial part in the diagnosis of cancer, and infectious diseases, and are extremely important since they provide insight into the immune system's resilience and help diagnose autoimmune disorders. The use of laboratory and patient-explicit assays is part of immunoprotein diagnostic testing which is based on the particular protein levels that were abnormal as well as whether the levels were too high or low.

In addition, the process of identifying and frequently characterizing the causative agent of an infectious disease is known as infectious disease diagnostics which uses methods such as molecular diagnostics, biochemical testing, microscopy, and microbial culture. Besides this, blood and blood diseases are studied in hematology which also involves an examination of hematopoiesis.

End-User Segment Analysis

The emergency rooms segment in the critical care diagnostics market is set to garner a notable share shortly. The primary focus of an emergency department and critical care unit is the patient's health; therefore, the emergency room treats patients with injuries that are immediately life-threatening and circumstances that call for rapid, emergency care. Emergency physicians should concentrate on providing patients who are seriously injured or unwell with prompt care since if they wait longer, they risk organ failure, and other negative consequences.

Our in-depth analysis of the global market includes the following segments:

          Type
  • Routine & Special Chemistry
  •  Flow Cytometry
  •  Hematology
  •  Immunoproteins
  •  Microbial & Infectious Disease
  • Coagulation Testing

          End-User
  • Operation Room
  •  Intensive Care Unit
  •  Emergency Rooms

          Product
  • Glucose Monitoring Kits
  • Cardiometabolic Monitoring Kits
  • Infectious Disease Testing Kits
  • Coagulation Monitoring Kits
  •  Cancer Markers Testing Kit
  • Hematology Testing Kits
  •  Pregnancy and Fertility Testing Kits
  • Cholesterol Test Strips
  •  Drugs-Of-Abuse Testing Kits
  •  Fecal Occult Testing Kits

          Prescription Mode
  • Prescription-Based Testing Kits
  • OTC Testing Kits
Vishnu Nair
Vishnu Nair
Head - Global Business Development

Customize this report to your requirements — connect with our consultant for personalized insights and options.

Critical Care Diagnostics Market Regional Analysis:

North American Market Insights

The critical care diagnostics market in North America industry is predicted to hold largest revenue share of 45% by 2035. The yearly growth rate of U.S. healthcare spending is currently over 1% higher than the GDP, and the amount spent on healthcare in the United States will total around USD 6 trillion by 2028, or over 15% of GDP. Particularly, in 2022, US healthcare spending increased by more than 4%. As a result, hospitals hugely investing in advanced diagnostic technologies, leading to an increase in accessibility to advanced imaging systems, and point-of-care testing devices necessary in critical care settings.

APAC Market Insights

The Asia Pacific critical care diagnostics market is estimated to the second largest revenue share, during the forecast period, led by the rising medical tourism. India has become a significant medical tourism hub in recent years, owing to its low-cost treatments, presence of highly skilled and specialized medical professionals, and state-of-the-art medical facilities. For instance, over the past ten years, medical tourism has brought in over USD 7 billion for India; in the next ten years, it is anticipated to reach around USD 43 billion.

Critical Care Diagnostics Market size
Get Strategic Analysis by Region Now: Request Free Sample PDF

Critical Care Diagnostics Market Players:

    • Abbott
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • F. Hoffmann-La Roche Ltd
    • Danaher
    • BD
    • EKF Diagnostics
    • bioMérieux, Inc.
    • Siemens Healthcare Private Limited
    • Chembio Diagnostics, Inc.
    • Bayer AG

Recent Developments

  • Abbott obtained approval from the U.S. Food and Drug Administration (FDA) for the company's industry-leading life support system, CentriMag Blood Pump for use with the CentriMag System a type of life support for people whose heart and lungs are not working, and to enable physicians more time to make critical care decisions for their patients.
  • F. Hoffmann-La Roche Ltd. announced the launch of the next-generation qPCR system, LightCycler PRO System to enable a portfolio of more than 200 LightMix Modular research assays, and to meet clinical needs in molecular diagnostics and tackle public health issues in addition to enabling users to create their tests.
  • Report ID: 5813
  • Published Date: Sep 16, 2025
  • Report Format: PDF, PPT
  • Get detailed insights on specific segments/region
  • Inquire about report customization for your industry
  • Learn about our special pricing for startups
  • Request a demo of the report’s key findings
  • Understand the report’s forecasting methodology
  • Inquire about post-purchase support and updates
  • Ask About Company-Level Intelligence Additions

Have specific data needs or budget constraints?

customer-service Inquiry Before Buying

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of critical care diagnostics is evaluated at USD 1.53 billion.

The global critical care diagnostics market size was worth over USD 1.46 billion in 2025 and is poised to grow at a CAGR of over 5.7%, reaching USD 2.54 billion revenue by 2035.

North America critical care diagnostics market will dominate around 45% share, driven by increased spending on healthcare and investment in advanced diagnostic technologies, forecast period 2026–2035.

Key players in the market include F. Hoffmann-La Roche Ltd, Danaher, BD, EKF Diagnostics, bioMérieux, Inc., Siemens Healthcare Private Limited, Chembio Diagnostics, Inc., Bayer AG.

Critical Care Diagnostics Market Report Scope

GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

Connect with our Expert

Radhika Pawar
Radhika Pawar
Senior Research Analyst
Inquiry Before Buying Request Free Sample PDF

Copyright @ 2025 Research Nester. All Rights Reserved.

footer-bottom-logos